PERSPECTA

News from every angle

← Back to headlines

Zimmer Biomet Raises 2026 Outlook After Strong Q2 Revenue

Zimmer Biomet reported a 4.8% year-over-year revenue increase in Q2 and subsequently raised its adjusted EPS forecast for 2026 to $8.47-$8.59. The company also increased its organic revenue growth projection to 2.25%-3.25%.

5 Aug, 18:41 — 5 Aug, 18:41
PostShare

Sources

Showing 1 of 2 sources
seeking-alphaMixed2h ago

Zimmer Biomet forecasts 2026 adjusted EPS of $8.47-$8.59 as it raises organic revenue growth to 2.25%-3.25%

Read full article →

Coverage Timeline

First report: Yahoo · 5 Aug, 16:15Full coverage: 2 · 2hWindow: 2h
Left-leaningCenterRight-leaning
Yahoo5 Aug, 16:15First to report

Zimmer Biomet reports 4.8% YoY revenue uptick in Q2; raises 2026 outlook

2h later
seeking-alpha5 Aug, 18:41Latest update

Zimmer Biomet forecasts 2026 adjusted EPS of $8.47-$8.59 as it raises organic revenue growth to 2.25%-3.25%

Related Stories

SpaceX Stock Plummets After Financial Results and AI Spending Concerns

13m ago

Wall Street Continues Upward Trend, Dow Jones Reaches New High

16m ago

Four Corners Property Trust Acquires Five Novant Health Urgent Care Properties for $11.7M

17m ago

Skyward Outlines $100M Buyback Authorization as Operating EPS Rises to $1.30

17m ago